In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Anand Sampath Biography and Net Worth

EVP of Masimo

Anand Sampath serves as Executive Vice President - Operations & Clinical Research of the Company. Prior to that, he served as Executive Vice President, Engineering since March 2007. He is an inventor on more than ten patents relating to patient monitoring, wireless networks and communications. From April 2006 to March 2007, Mr. Sampath was our Director of Systems Engineering. From October 1995 to March 2006, he held various positions, including Program Manager, Engineering Manager and Distinguished Member of Technical Staff, at Motorola, Inc. Mr. Sampath holds a B.S. in Engineering from Bangalore University.

What is Anand Sampath's net worth?: The estimated net worth of Anand Sampath is at least $4.83 million as of December 15th, 2020. Mr. Sampath owns 28,782 shares of Masimo stock worth more than $4,833,937 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Sampath may own. Learn More about Anand Sampath's net worth.
How do I contact Anand Sampath?: The corporate mailing address for Mr. Sampath and other Masimo executives is 52 DISCOVERY, IRVINE CA, 92618. Masimo can also be reached via phone at (949) 297-7000 and via email at [email protected]. Learn More on Anand Sampath's contact information.
Has Anand Sampath been buying or selling shares of Masimo?: Anand Sampath has not been actively trading shares of Masimo during the past quarter. Most recently, Anand Sampath sold 30,000 shares of the business's stock in a transaction on Tuesday, December 15th. The shares were sold at an average price of $265.59, for a transaction totalling $7,967,700.00. Following the completion of the sale, the executive vice president now directly owns 28,782 shares of the company's stock, valued at $7,644,211.38. Learn More on Anand Sampath's trading history.
Who are Masimo's active insiders?: Masimo's insider roster includes H. Cohen (Director), Jon Coleman (Insider), Joe Kiani (Founder, CEO & Chairman), Tao Levy (EVP), Thomas McClenahan (EVP), Adam Mikkelson (Director), Bilal Muhsin (COO), Craig Reynolds (Director), Anand Sampath (EVP), and Micah Young (CFO). Learn More on Masimo's active insiders.
Are insiders buying or selling shares of Masimo?: During the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 40,000 shares worth more than $5,446,800.00. The most recent insider tranaction occured on April, 26th when Director Craig B Reynolds sold 40,000 shares worth more than $5,446,800.00. Insiders at Masimo own 9.7% of the company. Learn More about insider trades at Masimo.
Information on this page was last updated on 4/26/2024.

Anand Sampath Insider Trading History at Masimo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2020	Sell	30,000	$265.59	$7,967,700.00	28,782
11/20/2019	Sell	15,000	$155.00	$2,325,000.00	27,518
6/14/2019	Sell	30,000	$142.39	$4,271,700.00	27,518
1/15/2019	Sell	30,000	$115.00	$3,450,000.00	42,518
11/28/2018	Sell	30,000	$110.00	$3,300,000.00
7/11/2017	Sell	40,000	$92.00	$3,680,000.00	20,000
11/1/2016	Sell	65,000	$55.04	$3,577,600.00	23,171
10/31/2016	Sell	51,345	$55.05	$2,826,542.25	23,171
11/6/2015	Sell	45,000	$42.00	$1,890,000.00

Anand Sampath Buying and Selling Activity at Masimo

Masimo Company Overview

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Today's Range

Now: $167.95

$163.80

$168.40

50 Day Range

MA: $141.16

$111.73

$167.63

2 Week Range

Now: $167.95

$91.60

$173.90

Volume

157,123 shs

Average Volume

674,569 shs

Market Capitalization

$8.99 billion

P/E Ratio

115.83

Dividend Yield

N/A

Beta

0.97

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad